UCHE OBUA: Open Payments
NPI 1265982466 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 29 payments from 7 companies in 2025. Trend: 2023 $129 · 2024 $697 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $336 |
| Otsuka America Pharmaceutical, Inc. | 9 | $184 |
| E.R. Squibb & Sons, L.L.C. | 4 | $84 |
| Neurocrine BioSciences, Inc. | 3 | $56 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
Products named: AUSTEDO XR, ABILIFY ASIMTUFII, UZEDY, COBENFY, INGREZZA, ABILIFY MAINTENA, Auvelity, Qelbree.
Industry payments across MI — which companies pay providers there.
